Cantor Equity [CEP] vs HCM II Acquisition [HOND] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 14 vital metrics comparison: Cantor Equity wins in 1 metrics, HCM II Acquisition wins in 3 metrics, with 2 ties. HCM II Acquisition appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Note: Limited metrics are available for comparison. Check other tabs for more detailed analysis.

MetricCantor EquityHCM II AcquisitionBetter
P/E Ratio (TTM)73.67N/AN/A
Price-to-Book Ratio3.022.18HCM II Acquisition
Debt-to-Equity Ratio0.010.00HCM II Acquisition
PEG Ratio-0.03N/AN/A
EV/EBITDA-906.51N/AN/A
Profit Margin (TTM)0.00%0.00%Tie
Operating Margin (TTM)0.00%0.00%Tie
Return on Equity1.51%N/AN/A
Return on Assets (TTM)-1.66%N/AN/A
Free Cash Flow (TTM)$-137,586N/AN/A
1-Year Return145.36%79.42%Cantor Equity
Enterprise Value$311.79M$485.18MHCM II Acquisition
Revenue per Share (TTM)$0N/AN/A
Earnings per Share (Diluted)$0.33N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Cantor Equity vs HCM II Acquisition Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Cantor Equity1.23%17.47%21.83%-11.12%129.79%136.86%
HCM II Acquisition4.14%16.95%54.85%60.99%68.58%78.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Cantor Equity145.36%146.10%146.10%146.10%146.10%146.10%
HCM II Acquisition79.42%79.42%79.42%79.42%79.42%79.42%

News Based Sentiment: Cantor Equity vs HCM II Acquisition

Cantor Equity

News sentiment data is not available for Cantor Equity at this time.

HCM II Acquisition

News based Sentiment: NEUTRAL

The month's primary event was the completion of a business combination and subsequent public listing of Daseke, Inc. This is a significant corporate event, but its impact on investment prospects is yet to be determined, making the overall sentiment neutral. The redemption of shares provides a clear outcome for existing investors.

View HCM II Acquisition News Sentiment Analysis

Performance & Financial Health Analysis: Cantor Equity vs HCM II Acquisition

MetricCEPHOND
Market Information
Market Cap i$250.88M$493.35M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i234,1103,079,671
90 Day Avg. Volume i250,5671,477,824
Last Close$24.61$17.87
52 Week Range$10.03 - $59.75$9.90 - $18.80
% from 52W High-58.81%-4.95%
All-Time High$59.75 (Apr 28, 2025)$18.80 (Oct 06, 2025)
% from All-Time High-58.81%-4.95%
Growth Metrics
Quarterly Revenue GrowthN/AN/A
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i0.00%0.00%
Operating Margin (TTM) i0.00%0.00%
Return on Equity (TTM) i0.02%N/A
Debt to Equity (MRQ) i0.010.00
Cash & Liquidity
Book Value per Share (MRQ)$-0.21$-0.49
Cash per Share (MRQ)$0.00$0.00
Operating Cash Flow (TTM) i$-47,478$-323,234
Levered Free Cash Flow (TTM) i$1.54M$0
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Cantor Equity vs HCM II Acquisition

MetricCEPHOND
Price Ratios
P/E Ratio (TTM) i73.67N/A
Forward P/E iN/AN/A
PEG Ratio i-0.03N/A
Price to Sales (TTM) iN/AN/A
Price to Book (MRQ) i3.022.18
Market Capitalization
Market Capitalization i$250.88M$493.35M
Enterprise Value i$311.79M$485.18M
Enterprise Value Metrics
Enterprise to Revenue iN/AN/A
Enterprise to EBITDA i-906.51N/A
Risk & Other Metrics
Beta iN/AN/A
Book Value per Share (MRQ) i$-0.21$-0.49

Financial Statements Comparison: Cantor Equity vs HCM II Acquisition

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CEPHOND
Revenue/Sales i$0$0
Cost of Goods Sold iN/AN/A
Gross Profit iN/AN/A
Research & Development iN/AN/A
Operating Income (EBIT) i$-443,105$-278,494
EBITDA i$-443,105$-278,494
Pre-Tax Income i$717,494$1.07M
Income Tax iN/AN/A
Net Income (Profit) i$717,494$1.07M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CEPHOND
Cash & Equivalents i$25,000$517,160
Total Current Assets i$317,000$682,955
Total Current Liabilities i$892,890$1.40M
Long-Term Debt iN/AN/A
Total Shareholders Equity i$102.57M$225.58M
Retained Earnings i$-2.01M$-12.08M
Property, Plant & Equipment iN/AN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CEPHOND
Operating Cash Flow i$-315,143$-273,494
Capital Expenditures iN/AN/A
Free Cash Flow i$0$-294,130
Debt Repayment i$-156,661N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCEPHOND
Shares Short i1.63M45,339
Short Ratio i5.980.10
Short % of Float i0.16%0.00%
Average Daily Volume (10 Day) i234,1103,079,671
Average Daily Volume (90 Day) i250,5671,477,824
Shares Outstanding i12.80M28.75M
Float Shares i6.30M21.05M
% Held by Insiders i0.03%0.00%
% Held by Institutions i0.65%0.99%

Dividend Analysis & Yield Comparison: Cantor Equity vs HCM II Acquisition

MetricCEPHOND
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A